<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mupirocin: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mupirocin: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Mupirocin: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="10881" href="/d/html/10881.html" rel="external">see "Mupirocin: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12622" href="/d/html/12622.html" rel="external">see "Mupirocin: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F198518"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Centany AT [DSC];</li>
<li>Centany [DSC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F198557"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Topical</li></ul></div>
<div class="block doa drugH1Div" id="F198521"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a70584bd-6d8a-446a-9488-76b0ef4d0e2b">Peritoneal dialysis catheter exit-site or tunnel infection, prophylaxis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Peritoneal dialysis catheter exit-site or tunnel infection, prophylaxis (off-label use): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical:</b> Cream: Apply once daily to catheter exit site to prevent infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27282851','lexi-content-ref-28341139']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27282851','lexi-content-ref-28341139'])">Ref</a></span>). <b>Note:</b> Cream is preferred to ointment, which may damage some catheters (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-14636007']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-14636007'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="00e35d0a-4e30-42f3-9500-5bc6cc0c3cd8">
<i>Staphylococcus aureus</i> decolonization</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Staphylococcus aureus</i> (including methicillin-resistant) decolonization:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For select patients who have recurrent <i>S. aureus</i> infection or warrant preoperative decolonization (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23327981','lexi-content-ref-21217178']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23327981','lexi-content-ref-21217178'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Intranasal (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note:</b> Intranasal mupirocin ointment is no longer available in the United States.</p>
<p style="text-indent:-2em;margin-left:6em;">Ointment: Apply into each nostril (an amount sufficient to cover the top of a cotton swab [~500 mg]) twice daily for 5 to 10 days in combination with a skin antiseptic (eg, chlorhexidine body wash); dose extrapolated from intranasal formulation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23327981','lexi-content-ref-20054045','lexi-content-ref-21217178','lexi-content-ref-24056477']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23327981','lexi-content-ref-20054045','lexi-content-ref-21217178','lexi-content-ref-24056477'])">Ref</a></span>). <b>Note:</b> Some experts suggest decolonization at discharge for hospitalized patients with methicillin-resistant <i>S. aureus </i>colonization or infection; in such cases, a 5-day course in combination with chlorhexidine body wash and mouthwash is repeated twice monthly for 6 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30763195']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30763195'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="731c98f9-eebd-47ac-b160-6aef5248377e">Superficial skin infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Superficial skin infection:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Folliculitis (off-label use):</i></b>
<b>Topical:</b> Ointment: Apply to affected area 3 times daily, typically for 7 days depending on severity and clinical response (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2516463','lexi-content-ref-2502567']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2516463','lexi-content-ref-2502567'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Impetigo (limited number of lesions):</i></b>
<b>Topical:</b> Ointment: Apply to affected area 2 to 3 times daily for 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2516463','lexi-content-ref-2502567','lexi-content-ref-24947530']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2516463','lexi-content-ref-2502567','lexi-content-ref-24947530'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Nasal vestibulitis (off-label use):</i></b>
<b>Intranasal:</b> Ointment: Apply to affected nostril(s) twice daily for 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bhattacharyya.1','lexi-content-ref-Wang.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bhattacharyya.1','lexi-content-ref-Wang.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Secondary skin infection (localized infection of wounds, burns, dermatitis, or other lesions):</i></b>
<b>Topical:</b> Cream, Ointment: Apply to affected area 2 to 3 times daily, typically for 7 to 14 days depending on severity and clinical response; if no response after 3 to 5 days, re-evaluate treatment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2502567','lexi-content-ref-Weston.2020','lexi-content-ref-2501394','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2502567','lexi-content-ref-Weston.2020','lexi-content-ref-2501394','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991983"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied).</p></div>
<div class="block doha drugH1Div" id="F50989210"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F198522"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F198538"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12622" href="/d/html/12622.html" rel="external">see "Mupirocin: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="00e35d0a-4e30-42f3-9500-5bc6cc0c3cd8">
<i>Staphylococcus aureus</i> decolonization</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Staphylococcus aureus</i> (methicillin-resistant or -susceptible) decolonization:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Nasal site: <b>Note: </b>Intranasal mupirocin ointment is no longer available in the United States; some dosing extrapolated from intranasal formulation.</p>
<p style="text-indent:-2em;margin-left:6em;">Infants, Children, and Adolescents: Ointment: Limited data available: Topical: Apply a small amount (eg, approximately pea-sized) to both anterior nares twice daily for 5 to 10 days; often used concomitantly with a skin decontamination regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-35450544','lexi-content-ref-32521007','lexi-content-ref-21217178','lexi-content-ref-35094904']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-35450544','lexi-content-ref-32521007','lexi-content-ref-21217178','lexi-content-ref-35094904'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="731c98f9-eebd-47ac-b160-6aef5248377e">Superficial skin infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Superficial skin infection:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Impetigo with limited lesions: Limited data available in ages &lt;2 months: Infants, Children, and Adolescents: Ointment: Topical: Apply to affected area 2 to 3 times daily for 5 days; patients not showing clinical response after 3 to 5 days should be reevaluated (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-1605593','lexi-content-ref-21217178','lexi-content-ref-24947530','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-1605593','lexi-content-ref-21217178','lexi-content-ref-24947530','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Secondary skin infection with minor skin lesions: Cream (limited data in ages &lt;3 months), Ointment (limited data available): Infants, Children, and Adolescents: Cream, Ointment: Topical: Apply to affected area 2 to 3 times daily for 7 to 10 days; patients not showing clinical response after 3 to 5 days should be reevaluated (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21217178','lexi-content-ref-2501394','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21217178','lexi-content-ref-2501394','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51130361"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied).</p></div>
<div class="block dohp drugH1Div" id="F51130362"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F198494"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Pruritus (≤1%), skin rash (≤1%), stinging of the skin (≤2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Nausea (≤1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local pain (≤2%), localized burning (≤2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Headache (2%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Cellulitis, dermatitis (including contract dermatitis), erythema of skin, xeroderma</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal pain, aphthous stomatitis</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Secondary infection (wound)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local swelling, localized tenderness</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Hypersensitivity: Hypersensitivity reaction (including anaphylaxis and angioedema)</p></div>
<div class="block coi drugH1Div" id="F198504"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to mupirocin or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F198491"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity: May be associated with systemic allergic reactions, including anaphylaxis, urticaria, angioedema, and generalized rash. If a systemic reaction occurs, discontinue use.</p>
<p style="text-indent:-2em;margin-left:4em;">• Irritation: If sensitization or local irritation occurs, discontinue use.</p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity ("gasping syndrome") in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Polyethylene glycol: Potentially toxic amounts of polyethylene glycol contained in some topical products may be absorbed percutaneously in patients with extensive burns or open wounds. Do not use polyethylene glycol-based ointments in conditions where absorption of large quantities of polyethylene glycol is possible, especially in the presence of moderate or severe renal impairment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For external use only. May cover treated areas with gauze dressing. Ointment should not be used with IV cannulae or at central IV sites because of the potential to promote fungal infections and antimicrobial resistance. Cream and ointment are not indicated for ophthalmic or nasal use or use on mucosal surfaces; in case of accidental contact in or near eyes, rinse well with water. If ointment applied intranasally (off-label use), may cause severe burning and tearing in eyes (resolves within days to weeks after discontinuation).</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878557"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F198500"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External, as calcium [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2% (15 g, 30 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Centany AT: 2% [DSC] [contains propylene glycol monostearate]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Centany: 2% (30 g [DSC]) [contains propylene glycol monostearate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2% (1 g, 15 g, 22 g)</p></div>
<div class="block geq drugH1Div" id="F198487"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F198507"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Mupirocin Calcium External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $1.81 - $16.37</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Mupirocin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $0.51 - $3.89</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F803172"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Intranasal</b> (ointment) (off-label route): After application into nostrils, press sides of nose together and gently massage to spread ointment throughout the insides of the nostrils for ~1 minute. Do not apply concurrently with any other intranasal products. Wash hands before and after application. In case of accidental contact in or near eyes, rinse well with water (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30763195']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30763195'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical</b> (cream, ointment): For external use only; not for use in eyes or on mucous membranes (components may be absorbed systemically and cause drying and irritation). Apply small amount to affected area using gauze pad or cotton swab; area may be covered with a gauze dressing if desired. In case of accidental contact in or near eyes, rinse well with water. Wash hands before and after application.</p></div>
<div class="block admp drugH1Div" id="F52613367"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: Wash hands before and after application.</p>
<p style="text-indent:-2em;margin-left:2em;">Ointment:</p>
<p style="text-indent:-2em;margin-left:4em;">Nasal site: Apply to anterior nares (enough to cover nasal mucosa); press sides of the nose together and gently massage for ~1 minute after application to spread ointment throughout the inside of the nostrils. Not for use in eyes. In case of accidental contact in or near eyes, rinse well with water. Do not apply concurrently with any other intranasal products (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bactroban.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bactroban.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Skin site (eg, umbilical site, impetigo, secondary skin infection): For external use only; not for use in eyes or on mucous membranes (components may be absorbed systemically and cause drying and irritation). Apply a small amount to affected area using cotton swab or gauze pad; may cover area with gauze dressing if desired. In case of accidental contact in or near eyes, rinse well with water. Do not use concurrently with any other lotions, creams, or ointments.</p>
<p style="text-indent:-2em;margin-left:2em;">Cream: Skin site (eg, umbilical site, impetigo, secondary skin infection): For external use only; not formulated for use on mucosal surfaces; do not apply into the eye or use intranasally (components may be absorbed systemically and cause drying and irritation). Apply a small amount to affected area using cotton swab or gauze pad; may cover area with gauze dressing if desired. In case of accidental contact in or near eyes, rinse well with water. Do not use concurrently with any other lotions, creams, or ointments.</p></div>
<div class="block use drugH1Div" id="F198501"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Impetigo:</b> Treatment of impetigo due to <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (topical ointment).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Secondary skin infection:</b> Treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm<sup>2</sup> in area) due to susceptible isolates of <i>S. aureus</i> and <i>S. pyogenes</i> (topical cream).</p></div>
<div class="block off-label drugH1Div" id="F25469178"><span class="drugH1">Use: Off-Label: Adult</span><p>Folliculitis; Nasal vestibulitis; Peritoneal dialysis catheter exit-site or tunnel infection, prophylaxis; Staphylococcus aureus (including methicillin-resistant) decolonization</p></div>
<div class="block mst drugH1Div" id="F198564"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Bactroban may be confused with bacitracin, baclofen, Bactrim</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299730"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F198495"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F198508"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Systemic absorption following topical application is minimal.</p></div>
<div class="block brc drugH1Div" id="F20616365"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if mupirocin is present in breast milk. Systemic absorption following topical application is minimal and significant exposure to a breastfeeding infant is not expected.</p>
<p style="text-indent:-2em;margin-left:2em;">The American Academy of Breastfeeding Medicine recommends topical mupirocin for superficial skin infection associated with skin trauma in breastfeeding patients (ABM [Berens 2016]). Mupirocin is applied after breastfeeding in conjunction with cleaning the affected area. Topical treatment is not effective for systemic infection that may lead to mastitis (Livingstone 1999).</p>
<p style="text-indent:-2em;margin-left:2em;">Per the manufacturer, if treatment to the breast and/or nipple is needed, the area should be thoroughly washed prior to breastfeeding to limit potential exposure of mupirocin to the infant; the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother.</p></div>
<div class="block pha drugH1Div" id="F198490"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Binds to bacterial isoleucyl transfer-RNA synthetase resulting in the inhibition of protein synthesis</p></div>
<div class="block phk drugH1Div" id="F198503"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Penetrates outer layers of skin; systemic absorption minimal through intact skin.</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: &gt;97%.</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Rapidly metabolized to monic acid (inactive) following IV or oral administration.</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life: IV: 20 to 40 minutes.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (as monic acid [inactive]).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F198509"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Avoban | Bactroban | Mupin | Mupirocin | Pirom | Supirocin</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupax | Mupirox | Paldar | Quemicetina nasal nf | Vidox</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Infectopyoderm</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Apo-mupirocin | Bactroban | Medicianz mupirocin | Medsurge mupirocin nasal</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Bacron | Bactoderm | Bactriben | Bactroban | Bactropen | Dermocin | Dermupin | Mupi | Mupibac | Mupiderm | Mupiron | Muroderm | Muron | Piroban | Sinaban | Systop | Trego</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupirodermal | Mupironasal</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Bacrocin | Bactocin | Bactroban | Bactroneo | Dermoban | Mupirocina | Supirocin</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Purocine</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bantix | Mupax | Mupax nasal | Mupicil | Paldar | Ultrabiotic | Underan</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bai duo bang</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupicare | Mupiral | Presiderm</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Infectopyoderm | Mupirocin infectopharm | Turixin</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Bactriderm | Bactroban | Mupifen | Mupiral | Presiderm | Supirocin</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Bagobiotic | Mupax | Mupiral | Paldar | Presiderm | Seladerm | Underan</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Humobact 15</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactrocin | Bactroform | Mupirax | Probactcin</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupirocina dermogen | Mupirocina isdin | Plasimine</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Baktocid | Solu m</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupiderm | Mupirocin sandoz | Mupirocine arrow | Mupirocine biogaran | Mupirocine eg | Mupirocine mylan | Mupirocine pierre fabre</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactrocine | Hevronaz | Micoban</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Bacterocin | Bactrian | Bactroban | Mupider | Muprin | Muropa | Supirocin</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Betrion mast | Mirobact | Mupiron</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactrocine | Mupirocin infectopharm</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Bactoderm | Bactroban | Mertus | Pibaksin</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Bactoderm | Bactroban</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">B bact | B fence | Bactibade | Bacticin | Bactroban | Baktocid | Dataron | Dermocin | Epicin | Lifecin | M sys | Mcin | Mocin | Mopry | Mpcin | Mpee | Mu | Mucidal | Mufect | Mupact | Mupibac | Mupibact | Mupiban | Mupic | Mupicet | Mupidac | Mupifen | Mupimesh | Mupin | Mupinase | Mupinity | Mupinova | Mupirax | Mupired | Mupirol | Mupiron | Mupisoft | Mupitret | Mupiways | Muply | Mupricon | Mupritis | Musaf | Pirocin | Rociderm | Sterbact | Supirocin | T-bact | Topibact</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactroban nasale | Mupiskin | Pserocina | Pserocina nasale</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Avoban | Bactroban | Bactroderm</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">B bact | Bactopic | Bactroban | Bactrobel | Mupisoft | Supirocin | Zupricin</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Antista | Bacterocin | Bactran | Bactrian | Bactroban | Bactrocin | Bearoban | Bentasone | Esroban | M picin | Mupiroban | Murocin | Murosin | Sy mupirocin</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Avoban | Bactroban</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Infectopyoderm | Turixin</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Turixin</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Bacskin | Bactroban | Berniver | Dermucor S | Mupirocina | Sinpebac</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Bactopic | Bactricin | Bactroban | Mupicin | Mupirocin | Muposten | Murozin | Pirobact | Supirocin</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Supirocin</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupirocine | Mupirocine PCH</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactroban nasal nordic prime | Infectopyoderm | Turixin</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Medicianz mupirocin</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Bagobiotic | Mupibiot | Mupiderm | Mupirocina | Mupirotrim | Mupirox | Murocyn | Setilax | Spectroderm | Supirocin | Underan</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Bactifree | Bactreat | Bactriderm | Bactrigon | Bactroban | Bactrocin | Dermpibac | Diapurocin | Flovicide | Foskina | Microscot | Mirocid | Mupi | Mupiban | Mupicin | Mupiderm | Mupizee | S troban | Supiroban</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Antibac skin | Austaban | Bactoderm | Bactroban | Impecin | Imperocin | Irocin | Lintoban | Mupex | Mupiderm | Mupir | Mupira | Mupiron | Mupream | Muricin | Murocen | Mutrum | Trego | Tryderm | Upirox | Verocin</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupina | Mupirox | Soltopin | Taconal</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Centany | Mupirocin</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupirocina | Mupirocina isdin</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bantix | Mupax | Mupax nasal | Mupirox | Underan</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Avoban | Bacoderm | Bactroban Cream | Bactroban Nasal | Bactroban Ointment | Dextrocin | Supirocin</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bonderm | Supirocin</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Avoban | Bactroban | Supirocin</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupirax | Muprin | Supirocin</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Betrion</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Acdhon | Bacidal | Bacobye | Bactafect | Bactex | Bacticin | Bactokil | Bactroban | Banbact | Macroban | Mulacin | Muporin | Muprin | Piroban | Supirocin</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Bacoderm | Bactroban | Balaban | Dextrocin | Mupiderm | Mupiron | Mupobel</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Bactermin | Bactroban</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Bactialis | Bactopic | Bactroban | Bonderm</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Bactroban ointment | Supirocin</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Mupax | Mupilav | Mupirin | Mupirin nasal | Vidox</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Dalcitrin | Multiderm | Muproban | Presiderm</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Atimupicin | Phitrenone | Tropeal</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Banogon | Dermoban | Nuban | Supiroban</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Monsin | Supirocin | Topibact</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Bactroban | Supirocin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35450544">
<a name="35450544"></a>Arora HS, Khan H, Ailumerab H, et al. A tale of two intensive care units (ICUs): baseline <i>Staphylococcus aureus</i> colonization and mupirocin susceptibility in neonatal and pediatric patients requiring intensive care. <i>Infect Control Hosp Epidemiol</i>. 2023;44(3):447-452. doi:10.1017/ice.2022.96<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/35450544/pubmed" id="35450544" target="_blank">35450544</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bactroban.2">
<a name="Bactroban.2"></a>Bactroban (mupirocin) nasal ointment [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; March 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26881962">
<a name="26881962"></a>Berens P, Eglash A, Malloy M, Steube AM. ABM clinical protocol #26: persistent pain with breastfeeding. <i>Breastfeed Med</i>. 2016;11(2):46-53.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/26881962/pubmed" id="26881962" target="_blank">26881962</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16755477">
<a name="16755477"></a>Bertin ML, Vinski J, Schmitt S, et al, "Outbreak of Methicillin-Resistant <i>Staphylococcus aureus</i> Colonization and Infection in a Neonatal Intensive Care Unit Epidemiologically Linked to a Healthcare Worker With Chronic Otitis," <i>Infect Control Hosp Epidemiol</i>, 2006, 27(6):581-5.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/16755477/pubmed" id="16755477" target="_blank">16755477</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bhattacharyya.1">
<a name="Bhattacharyya.1"></a>Bhattacharyya N. Nasal obstruction: Diagnosis and management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 17, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20054045">
<a name="20054045"></a>Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of <i>Staphylococcus aureus</i>. <i>N Engl J Med</i>. 2010;362(1):9-17. doi:10.1056/NEJMoa0808939<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/20054045/pubmed" id="20054045" target="_blank">20054045</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2516463">
<a name="2516463"></a>Bork K, Brauers J, Kresken M. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial. <i>Br J Clin Pract</i>. 1989;43(8):284‐288.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/2516463/pubmed" id="2516463" target="_blank">2516463</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bradley.2">
<a name="Bradley.2"></a>Bradley JS, Nelson JD, Barnett ED, et al, eds. <i>Nelson's Pediatric Antimicrobial Therapy</i>. 29th ed. American Academy of Pediatrics; 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23327981">
<a name="23327981"></a>Bratzler DW, Dellinger EP, Olsen KM, et al; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. <i>Am J Health Syst Pharm</i>. 2013;70(3):195‐283. doi:10.2146/ajhp120568<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/23327981/pubmed" id="23327981" target="_blank">23327981</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1605593">
<a name="1605593"></a>Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant <i>Staphylococcus aureus</i> strains. <i>Antimicrob Agents Chemother</i>. 1992;36(2):287-290. doi:10.1128/AAC.36.2.287<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/1605593/pubmed" id="1605593" target="_blank">1605593</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27458596">
<a name="27458596"></a>Duggal SD, Bharara T, Jena PP, et al. Staphylococcal bullous impetigo in a neonate. <i>World J Clin Cases</i>. 2016;4(7):191-194. doi:10.12998/wjcc.v4.i7.191<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/27458596/pubmed" id="27458596" target="_blank">27458596</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2502567">
<a name="2502567"></a>Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. <i>J Am Acad Dermatol</i>. 1989;20(6):1083‐1087. doi:10.1016/s0190-9622(89)70137-7<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/2502567/pubmed" id="2502567" target="_blank">2502567</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3149884">
<a name="3149884"></a>Goldfarb J, Crenshaw D, O'Horo J, et al. Randomized Clinical Trial of Topical Mupirocin Versus Oral Erythromycin for Impetigo. <i>Antimicrob Agents Chemother</i>. 1988;32(12):1780-1783.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/3149884/pubmed" id="3149884" target="_blank">3149884</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32521007">
<a name="32521007"></a>Hogan PG, Parrish KL, Mork RL, et al. HOME2 study: household versus personalized decolonization in households of children with methicillin-resistant <i>Staphylococcus aureus</i> skin and soft tissue infection-a randomized clinical trial. <i>Clin Infect Dis</i>. 2021;73(11):e4568-e4577. doi:10.1093/cid/ciaa752<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/32521007/pubmed" id="32521007" target="_blank">32521007</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30763195">
<a name="30763195"></a>Huang SS, Singh R, McKinnell JA, et al. Decolonization to reduce postdischarge infection risk among MRSA carriers. <i>N Engl J Med</i>. 2019;380(7):638‐650. doi:10.1056/NEJMoa1716771<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/30763195/pubmed" id="30763195" target="_blank">30763195</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25742074">
<a name="25742074"></a>Huang YC, Lien RI, Lin TY. Effect of mupirocin decolonization on subsequent methicillin-resistant <i>Staphylococcus aureus</i> infection in infants in neonatal intensive care units. <i>Pediatr Infect Dis J</i>. 2015;34(3):241-245.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/25742074/pubmed" id="25742074" target="_blank">25742074</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14636007">
<a name="14636007"></a>Khandelwal M, Bailey S, Izatt S, et al. Structural changes in silicon rubber peritoneal dialysis catheters in patients using mupirocin at the exit site. <i>Int J Artif Organs</i>. 2003;26(10):913‐917. doi:10.1177/039139880302601007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/14636007/pubmed" id="14636007" target="_blank">14636007</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30587533">
<a name="30587533"></a>Kotloff KL, Shirley DT, Creech CB, et al. Mupirocin for <i>Staphylococcus aureus</i> decolonization of infants in neonatal intensive care units. <i>Pediatrics</i>. 2019;143(1):e20181565. doi:10.1542/peds.2018-1565<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/30587533/pubmed" id="30587533" target="_blank">30587533</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9866667">
<a name="9866667"></a>Kraus SJ, Eron LJ, Bottenfield GW, Drehobl MA, Bushnell WD, Cupo MA. Mupirocin cream is as effective as oral cephalexin in the treatment of secondarily infected wounds. <i>J Fam Pract</i>. 1998;47(6):429-433.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/9866667/pubmed" id="9866667" target="_blank">9866667</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24056477">
<a name="24056477"></a>Lee AS, Cooper BS, Malhotra-Kumar S, et al; MOSAR WP4 Study Group. Comparison of strategies to reduce methicillin-resistant <i>Staphylococcus aureus</i> rates in surgical patients: a controlled multicenter intervention trial. <i>BMJ Open</i>. 2013;3(9):e003126. doi:10.1136/bmjopen-2013-003126<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/24056477/pubmed" id="24056477" target="_blank">24056477</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27282851">
<a name="27282851"></a>Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment [published correction appears in <i>Perit Dial Int</i>. 2018;38(4):313]. <i>Perit Dial Int</i>. 2016;36(5):481‐508. doi:10.3747/pdi.2016.00078<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/27282851/pubmed" id="27282851" target="_blank">27282851</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21217178">
<a name="21217178"></a>Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> infections in adults and children: executive summary. <i>Clin Infect Dis</i>. 2011;52(3):285‐292. doi:10.1093/cid/cir034<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/21217178/pubmed" id="21217178" target="_blank">21217178</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10578803">
<a name="10578803"></a>Livingstone V, Stringer LJ. The treatment of <i>Staphyloccocus aureus</i> infected sore nipples: a randomized comparative study. <i>J Hum Lact</i>. 1999;15(3):241-246.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/10578803/pubmed" id="10578803" target="_blank">10578803</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35901469">
<a name="35901469"></a>McKeown KE, Baker RB. Staphylococcal scalded skin syndrome, identification, and wound care: a case report series. <i>Adv Neonatal Care</i>. 2022;22(4):325-332. doi:10.1097/ANC.0000000000000979<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/35901469/pubmed" id="35901469" target="_blank">35901469</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Northstar.1">
<a name="Northstar.1"></a>Mupirocin (USP, 2%) cream [prescribing information]. Memphis, TN: Northstar RxLLC; November 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Padagis.1">
<a name="Padagis.1"></a>Mupirocin (USP, 2%) ointment [prescribing information]. Allegan, MI: Padagis; January 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34023342">
<a name="34023342"></a>Nelson MU, Shaw J, Gross SJ. Randomized placebo-controlled trial of topical mupirocin to reduce <i>Staphylococcus aureus</i> colonization in infants in the neonatal intensive care unit. <i>J Pediatr</i>. 2021;236:70-77. doi:10.1016/j.jpeds.2021.05.042<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/34023342/pubmed" id="34023342" target="_blank">34023342</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35094904">
<a name="35094904"></a>Savary L, De Luca A, El Arid JM, et al. Systematic skin and nasal decolonization lowers <i>Staphylococcus</i> infection in pediatric cardiac surgery. <i>Arch Pediatr</i>. 2022;29(3):177-182. doi:10.1016/j.arcped.2022.01.009<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/35094904/pubmed" id="35094904" target="_blank">35094904</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29762388">
<a name="29762388"></a>Simon A, Dresbach T, Müller A. Methicillin-resistant <i>Staphylococcus aureus</i> decolonization in neonates and children. <i>Pediatr Infect Dis J</i>. 2018;37(6):612-614. doi:10.1097/INF.0000000000001982<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/29762388/pubmed" id="29762388" target="_blank">29762388</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24947530">
<a name="24947530"></a>Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2014;59(2):147-159.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/24947530/pubmed" id="24947530" target="_blank">24947530</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28341139">
<a name="28341139"></a>Tsai CC, Yang PS, Liu CL, Wu CJ, Hsu YC, Cheng SP. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: a systematic review and meta-analysis. <i>Am J Surg</i>. 2018;215(1):179‐185. doi:10.1016/j.amjsurg.2017.03.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/28341139/pubmed" id="28341139" target="_blank">28341139</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Wang.1">
<a name="Wang.1"></a>Wang MB. Etiologies of nasal obstruction: An overview. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 17, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Weston.2020">
<a name="Weston.2020"></a>Weston WL, Howe W. Treatment of atopic dermatitis (eczema). Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 23, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2501394">
<a name="2501394"></a>White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate. <i>J Infect</i>. 1989;18(3):221‐229. doi:10.1016/s0163-4453(89)80058-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/2501394/pubmed" id="2501394" target="_blank">2501394</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28704818">
<a name="28704818"></a>Wisgrill L, Zizka J, Unterasinger L, et al. Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible <i>Staphylococcus aureus</i> infections in VLBW infants. <i>Neonatology</i>. 2017;112(3):267-273.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mupirocin-drug-information/abstract-text/28704818/pubmed" id="28704818" target="_blank">28704818</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9668 Version 375.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
